Modeling Results of Pricing Scenarios for “Express Travel Choices Study” CDM Smith, ATDOD LA, FRVR Mileage-Based, FRV Rate, MBU Fee Transportation Research 13, 6069, 2035 | | 2035 |
Imaging Beneath Mud Volcanoes in the Caspian Sea via Visco-Acoustic Full-Waveform Inversion and Q-Imaging S Madden, K Mistry, Z Chen, C Smith, K Lenette, H Asgerov, E Yusifov, ... 85th EAGE Annual Conference & Exhibition (including the Workshop Programme …, 2024 | | 2024 |
Septins provide microenvironment sensing and cortical actomyosin partitioning in motile amoeboid T lymphocytes AS Zhovmer, A Manning, C Smith, A Nguyen, O Prince, PJ Sáez, X Ma, ... Science Advances 10 (1), eadi1788, 2024 | 2 | 2024 |
Everybody’s business: Early intervention and crime reduction. Understanding and enhancing the role of police and multi-agency partners in preventing harms that cross the public … Z Quigg, C Smith, K Hughes, C Wilson, N Butler, L Jones, MA Bellis Public Health Institute, LJMU, 2023 | | 2023 |
Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial C Roffe, A Warusevitane, C Smith, A Dixit, N Sprigg, R Ogollah, J Sim, ... | | 2023 |
THE IMPACT OF INTENSIVE LIPID MANAGEMENT ON CARDIOVASCULAR RISK AFTER ISCHAEMIC STROKE-MODELLING ANALYSIS OF REAL WORLD DATA C Smith, S Wallis, A Cameron, J Dawson INTERNATIONAL JOURNAL OF STROKE 18 (3), 101-101, 2023 | | 2023 |
PIOGLITAZONE MODELLING AS A SECONDARY PREVENTION STRATEGY AFTER ISCHAEMIC STROKE S Wallis, C Smith, A Cameron, J Dawson INTERNATIONAL JOURNAL OF STROKE 18 (3), 129-129, 2023 | | 2023 |
Clinical and epidemiological features of psoriasis exacerbations in children with SARS‐CoV‐2 infection S Skrek, V Di Lernia, A Beauchet, AC Bursztejn, A Belloni Fortina, ... Journal of the European Academy of Dermatology and Venereology 37 (10 …, 2023 | | 2023 |
A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 21 | 2023 |
70 Decision to Incision Time: Can the Principle Be Applied to Emergency General Surgery in Order to Tackle Delays in Patient Care? C Smith, E Aly British Journal of Surgery 110 (Supplement_7), znad258. 356, 2023 | | 2023 |
4 A Quantitative Image Analysis Study of Modified Kessler Extensor Repair A Kathiravelupillai, C Smith, R Pearl British Journal of Surgery 110 (Supplement_7), znad258. 067, 2023 | | 2023 |
Metformin has anti-inflammatory effects and induces immunometabolic reprogramming in hidradenitis suppurativa via multiple mechanisms. A Petrasca, R Hambly, N Kearney, CM Smith, EK Pender, J Mac Mahon, ... The British Journal of Dermatology, ljad305-ljad305, 2023 | 1 | 2023 |
Atopic polygenic risk score is associated with paradoxical eczema developing in patients with psoriasis treated with biologics A Al-Janabi, S Eyre, AC Foulkes, AR Khan, N Dand, E Burova, B DeSilva, ... Journal of Investigative Dermatology 143 (8), 1470-1478. e1, 2023 | 10 | 2023 |
DEVELOPMENT OF NOVEL IMMUNOTHERAPEUTICS FOR EBV ASSOCIATED DISEASES IN PRECLINICAL SETTINGS S Muralidhar, C Smith, R Khanna, K Lineburg Cytotherapy 25 (6), S242-S242, 2023 | | 2023 |
Immunotherapy: RAPID ACCESS TO VIRUS-SPECIFIC T CELLS FOR ADOPTIVE IMMUNOTHERAPY FOR COMPASSIONATE USE IN AUSTRALIA MA Neller, GA Thomas, A Panikkar, L Beagley, S Rehan, S Best, J Raju, ... Cytotherapy 25 (6), S243, 2023 | | 2023 |
Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2 A Henden, K Lineburg, L Le Texier, J Raju, P Crooks, E Wright, A Scott, ... Cytotherapy 25 (6), S252, 2023 | | 2023 |
Immunotherapy: ALLOGENEIC T-CELL IMMUNOTHERAPY (CE-VST01-JC) FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) USING A HLA-DEFINED PEPTIDE PLATFORM GA Thomas, C Smith, S Best, L Beagley, A Panikkar, D Porter, R Khanna Cytotherapy 25 (6), S211-S212, 2023 | | 2023 |
Immunotherapy: HARNESSING SURFACE EXPRESSION TO DEFINE A UNIQUE MEMORY T CELL SUBSET WITH STEM-LIKE PROPERTIES TO ENHANCE ADOPTIVE T CELL THERAPIES K Lineburg, A Panikkar, S Srihari, P Khaledi, T Le, L Le Texier, P Martins, ... Cytotherapy 25 (6), S236, 2023 | | 2023 |
1045 Differential dysregulation of the AHR/CYP1A1 axis in psoriasis skin and blood M Ashoori, J Hardman-Smart, H Dawe, T Isabella, E Wincent, J Barker, ... Journal of Investigative Dermatology 143 (5), S179, 2023 | | 2023 |
448 A framework to study the epidemiological and molecular basis of psoriasis severity, with application in UK Biobank and BSTOP J Saklatvala, R Ramessur, M Simpson, SM Langan, S Brown, ... Journal of Investigative Dermatology 143 (5), S77, 2023 | | 2023 |